Drug class in one race
5-HT2A receptor drugs for Major Depressive Disorder
8 tracked 5-HT2A receptor drugs in the Major Depressive Disorder race. The class explanation lives on the 5-HT2A receptor page; the full indication pipeline across every mechanism is on the Major Depressive Disorder page.
3 Phase 34 Phase 21 Phase 1/2
Head-to-head evidence: BPL-003 (mebufotenin benzoate) vs Bretisilocin · BPL-003 (mebufotenin benzoate) vs CYB003 · BPL-003 (mebufotenin benzoate) vs ELE-101 · BPL-003 (mebufotenin benzoate) vs Lysergide tartrate (LSD) · BPL-003 (mebufotenin benzoate) vs Mebufotenin (5-MeO-DMT) · BPL-003 (mebufotenin benzoate) vs Psilocybin (COMP360)